Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Arthritis Rheum ; 49(1): 93-100, 2003 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-12579599

RESUMEN

OBJECTIVE: Because the optimal cyclophosphamide (CY) treatment duration for severe polyarteritis nodosa (PAN) without virus infection and microscopic polyangiitis (MPA) has not been established, we conducted a trial to compare the effectiveness of 6 versus 12 CY pulses given in combination with corticosteroids (CS). METHODS: Sixty-five (18 PAN, 47 MPA) previously untreated patients were randomized to receive 12 (n = 34) or 6 (n = 31) CY pulses combined with CS. PAN and MPA were histologically proven or met ACR criteria. All patients presented >or=1 factor of severity according to the five factor score (FFS). CY pulses were administered every 2 weeks for 1 month, then every 4 weeks. The end point of the study was the number of events (relapses and/or deaths) occurring in each group, analyzed according to an intention-to-treat strategy. The outcome was evaluated by Cox proportional hazards analysis. RESULTS: The baseline characteristics were similar for both groups. The mean (+/- SD) followup was 32 +/- 21 months. Survival analysis showed a significantly lower relapse probability (P = 0.02; hazards ratio [HR] = 0.34) and higher event-free survival (P = 0.02, HR = 0.44) for the 12 CY-pulse group while the mortality rates were not significantly different (P = 0.47). CONCLUSION: These results suggest that 6 CY pulses are less effective than 12 CY pulses to treat severe PAN and MPA, particularly with respect to the risk of relapses.


Asunto(s)
Antirreumáticos/administración & dosificación , Ciclofosfamida/administración & dosificación , Glucocorticoides/administración & dosificación , Poliarteritis Nudosa/tratamiento farmacológico , Adulto , Anciano , Antirreumáticos/efectos adversos , Ciclofosfamida/efectos adversos , Femenino , Estudios de Seguimiento , Glucocorticoides/efectos adversos , Humanos , Masculino , Microcirculación , Persona de Mediana Edad , Poliarteritis Nudosa/mortalidad , Pronóstico , Estudios Prospectivos , Quimioterapia por Pulso , Análisis de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA